Pfizer Accuretic Cancer Lawsuits
According to a press release issued by Pfizer, the company is recalling Accuretic, a blood pressure medication, due to dangerous levels of nitrosamine. Nitrosamine can increase a person’s risk of developing cancer. Pfizer states that the recall is a voluntary recall that affects six lots of Accuretic tablets, four lots of quinapril HCl/ hydrochlorothiazide tablets, and one lot of quinapril and hydrochlorothiazide tablets. The level of nitrosamine discovered in these lots exceed the acceptable daily intake.
According to Pfizer’s recall notice, nitrosamines can be found in water and foods, such as grilled and cured meats, vegetables, and dairy products. The recall notice also states that everyone is exposed to nitrosamines. However, nitrosamines may increase the risk of cancer when people are exposed to nitrosamines above acceptable levels for extended periods of time.
Pfizer conveyed that it is “not aware of reports of adverse events that have been assessed to be related to this recall.” Pfizer admitted that long-term N-nitroso-quinapril consumption is associated with potential increased cancer risks.
Medical professionals are advised to consult with their patients about changes in treatment. Patients and pharmacists are urged to find alternative treatments. Discontinuing the recalled medication might cause more harm than continuing on the medication.
The recalled products come in 90-count bottles and include the following information:
Accuretic (quinapril HCl/hydrochlorothiazide) tablets, 10/12.5 mg
- NDC: 0071-3112-23; Lot number: FG5379; Expiration date: August 2024
- NDC: 0071-0222-23; Lot number: EA6686; April 2022
Accuretic (quinapril HCl/hydrochlorothiazide) tablets, 20/12.5 mg
- NDC: 0071-5212-23; Lot number: FG5381; Expiration date: August 2024
- NDC: 0071-0220-23; Lot number: EA6665; Expiration date: April 2022
- NDC: 0071-0220-23; Lot number: CN0640; Expiration date: April 2022
Accuretic (quinapril HCl/hydrochlorothiazide) tablets, 20/25 mg
- NDC: 0071-0223-23; Lot number: ET6974; Expiration date: February 2023
Quinapril and hydrochlorothiazide tablets, 20/25 mg:
- NDC: 59762-5225-9; Lot number: FE3714; Expiration date: February 2023
Quinapril HCl/hydrochlorothiazide tablets, 20/12.5 mg:
- NDC: 59762-0220-1; Lot number: DN6931; Expiration date: March 2023
- NDC: 59762-0220-1; Lot number: ED3904; Expiration date: March 2023
- NDC: 59762-0220-1; Lot number: ED3905; Expiration date: March 2023
Quinapril HCl/hydrochlorothiazide tablets, 20/25 mg
- NDC: 59762-5225-9; Lot number: FE3714; Expiration date: February 2023
Pfizer urges patients who are prescribed one of the recalled products to consult with their doctor or pharmacy to see if they have a recalled product.
CONTACT PARKER WAICHMAN LLP FOR A FREE CASE REVIEW
Did you or a loved one suffer harm caused by recalled medications? Parker Waichman LLP helps those who have suffered injuries after using defective vehicles receive full monetary compensation. Trust your case with our product liability lawyers. For a free consultation, contact our law firm today by using our live chat or calling 1-800-YOUR-LAWYER (1-800-968-7529).
